Changes to the website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: , which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4882

Next 25



	Website Changes

	11/19/2019		Publication in Nature Communications Confirms DRD2 as Target of ONC201

	11/19/2019		RESULTS OF PHASE II CLINICAL TRIAL OF ONCOLYTIC HERPES VIRUS G47? IN PATIENTS WITH GLIOBLASTOMA


	11/18/2019		Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.

	11/18/2019		Another paid survey!


	11/13/2019		Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

	10/27/2019		Musella Foundation Online Support Groups are moving!


	10/26/2019		NYU Langone Health launches new molecular assay to identify patients with brain tumors

	10/24/2019		GBM patient and Caregiver Survey


	10/22/2019		Donate or request expensive medicines!

	10/10/2019		Oncology Pioneer xCures Names Experts to Advisory Boards


	10/10/2019		New Trial of Focused Ultrasound in Glioblastoma: Opening the Blood-Brain Barrier for Chemotherapy

	10/10/2019		First-line treatment of ONC 201 in newly diagnosed DIPG pediatric patients is now open.


	10/09/2019		Any Amazon users?

	09/30/2019		Optune Open House


	09/27/2019		Barriers to accrual and enrollment in brain tumor trials

	09/25/2019		Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress


	09/14/2019		DeAngelis named MSK physician-in-chief, chief medical officer

	09/13/2019		Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer


	09/11/2019		Frankly Speaking About Brain Tumors

	09/11/2019		Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients


	09/09/2019		Bristol-Myers Squibb`s Opdivo fails 3rd straight test in tough-to-treat brain cancer

	09/09/2019		Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting


	08/30/2019		Musella Foundation awards a pediatric brain tumor research grant!

	08/15/2019		DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)


	08/15/2019		Attend an Optune Open House